Ionis Pharmaceuticals Inc. (NASDAQ:IONS) – Equities research analysts at Leerink Swann issued their Q2 2017 earnings per share estimates for Ionis Pharmaceuticals in a report released on Monday. Leerink Swann analyst P. Matteis expects that the firm will post earnings of ($0.30) per share for the quarter. Leerink Swann has a “Market Perform” rating and […]
